Abzena plc is a biopharmaceutical services company that specializes in the development and manufacturing of biologics and antibody-drug conjugates (ADCs). Operating internationally, it provides a comprehensive range of technologies and solutions that support the discovery, development, and production of biopharmaceutical products. Abzena's offerings include advanced antibody engineering, immunogenicity assessment, and various bioassay and bioanalytic services. The company assists clients from initial concept through to clinical development, focusing on enhancing the efficacy and safety of biotherapeutics. Its services also encompass peptide synthesis, process development, and the characterization of drug conjugates. By partnering with biopharmaceutical companies and academic institutions, Abzena aims to drive innovation and improve therapeutic outcomes for patients. Founded in 2014 and headquartered in Cambridge, United Kingdom, Abzena has positioned itself as a key player in the biologics research sector.
PacificGMP Inc. is a contract manufacturing organization, engages in developing and manufacturing biologics. It produces monoclonal antibodies, recombinant proteins, vaccine products, insect cell/baculovirus, anchorage and suspension cells, and gene therapy products.
PolyTherics
Acquisition in 2013
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Antitope
Acquisition in 2013
Antitope Ltd is a biotechnology research company, develops non-immunogenic protein therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.